Improved intravenous lentiviral gene therapy based on endothelial-specific promoter-driven factor VIII expression for hemophilia A.

Gong, Jie; Yang, Rui; Zhou, Min; Chang, Lung-Ji

Gong, Jie; Yang, Rui; Zhou, Min; Chang, Lung-Ji.

Afiliación

Gong J; Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, 611731, China.
Yang R; School of Medicine, University of Electronic Science and Technology of China, Chengdu, 610054, China.
Zhou M; School of Medicine, University of Electronic Science and Technology of China, Chengdu, 610054, China.
Chang LJ; Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, 611731, China.

Mol Med ; 29(1): 74, 2023 06 12.

Article en En | MEDLINE | ID: mdl-37308845

Asunto(s)

Factor VIII; Hemofilia A; Humanos; Animales; Ratones; Coagulación Sanguínea; Línea Celular; Terapia Genética; Ratones Noqueados

Palabras clave

Endothelial-specific; Factor VIII; Gene therapy; Hemophilia A; Lentiviral vector

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Factor VIII / Hemofilia A Límite: Animals / Humans Idioma: En Revista: Mol Med Asunto de la revista: BIOLOGIA MOLECULAR Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google